On December 2, 2024, Naresuan University, Welala Company, and INVITROCUE LTD signed a collaboration agreement to establish an internationally standardized pre-clinical animal testing laboratory. The objective is to support research anIn a significant step forward for pre-clinical research and development, Naresuan University has joined forces with Welala Company and INVITROCUE LTD to establish an advanced animal testing laboratory. Officially signed on December 2, 2024, this collaboration aims to create a facility meeting international standards, designed to support the development of innovative treatments for a wide range of diseases. The initiative also seeks to attract research clients globally, further positioning Thailand as a hub for cutting-edge scientific discovery.d development of various disease treatments and attract research clients from around the world.
A Comprehensive Approach to Pre-Clinical Testing
The partnership encompasses pre-clinical testing for diverse products such as pharmaceuticals, vaccines, medical devices, nutritional supplements, cosmetics, and herbal remedies. Key areas of collaboration include knowledge exchange, personnel development, and specialized training programs to equip researchers and industry professionals with the skills needed to excel in a rapidly evolving scientific landscape.
Vision for Regional Leadership
Dr. Pongthorn Chotikasemsi, CEO of Welala Company, emphasized the strategic vision behind the project. “Our goal is to transform Naresuan University into a leading research and development center for new disease treatments within ASEAN,” he stated. Central to this vision is a commitment to fostering local talent, with plans to employ 6-20 Thai graduates and provide continuous technology training. This initiative will not only enhance research capabilities but also create meaningful opportunities for Thailand’s scientific community.
Driving Innovation and Global Collaboration
This cutting-edge laboratory promises to play a pivotal role in advancing scientific innovation while adhering to rigorous ethical standards. By combining academic expertise with industry insights, Naresuan University, Welala, and INVITROCUE aim to address critical healthcare challenges and contribute to global efforts in disease treatment and prevention.
